Innate Immune Pathway Activation To Modulate Mesenchymal Stromal Cell (MSC) Interaction With Synovium And Cartilage
Ontology highlight
ABSTRACT: Osteoarthritis (OA) is a progressive degenerative condition prevalent in aged animals and humans. Regenerative cellular therapies have emerged as a treatment option for OA with mixed results in efficacy which have been attributed in part to heterogeneity within stromal cell populations and between donors. Activation of mesenchymal stromal cells (MSC) by priming their ligands prior to administration has been demonstrated as a means to generate more homogenous cell populations thereby potentially achieving more consistent outcomes with cell therapy administration. We have demonstrated improved functional and histological outcomes in a murine destabilization of the medial meniscus model of OA with primed MSC therapy. Therefore, the goal of this study was to evaluate and compare the immunomodulatory properties of two ligands on cytokine and gene expression of MSC themselves and the effect of primed MSC conditioned media on key joint cells to further understand that observed effect mechanistically in the context of OA.
ORGANISM(S): Equus caballus
PROVIDER: GSE277125 | GEO | 2025/02/28
REPOSITORIES: GEO
ACCESS DATA